| ¿µ¹® | sodium | ÇÑ±Û | ³ªÆ®·ý |
|---|---|---|---|
| ¼³¸í | ¿øÀÚ¹øÈ£ 11ÀÇ ±Ý¼Ó¿øÀÚ. ¼¼Æ÷ ¿Ü¾×ÀÇ °¡Àå ÈçÇÑ ¾çÀÌ¿ÂÀ¸·Î¼ ¼¼Æ÷ ¿Ü¾×ÀÇ »ïÅõ¾Ð°áÁ¤¿¡ °¡Àå Áß¿äÇÑ ¿ªÇÒÀ» ÇÔ. ¾Ëµµ½ºÅ×·Ð(aldosterone: ÄáÆÏÀ§¿¡ ÀÖ´Â ºÎ½Å¿¡¼ ºÐºñÇÑ´Ù. Ç÷¾×³»ÀÇ »ïÅõ¾ÐÀ¯Áö¿¡ Áß¿äÇÑ ÀÛ¿ëÀ» ÇÑ´Ù)¿¡ ÀÇÇØ ÄáÆÏ¿¡¼ ÀçÈí¼ö°¡ ÃËÁøµÇ¸ç ü³» ¼öºÐ·®À» °áÁ¤ÇÏ´Â °¡Àå Áß¿äÇÑ ÀÎÀÚ. ½Å°æ¼¼Æ÷ µîÀÇ ÈïºÐ¼º ¼¼Æ÷ÀÇ ÈïºÐ½Ã ¼¼Æ÷³»·Î À¯ÀԵǾî ÈïºÐÀ» À¯¹ßÇÏ´Â Áß¿äÇÑ ±â´Éµµ °¡Áø´Ù. |
||
| ACD | absolute cardiac dullness; absolute claudication distance; acid-citrate-dextrose [solution]; actinom... |
|---|---|
| SSC | single-strand conformational [analysis]; sister strand crossover; somatosensory cortex; standard sal... |
| PSL | parasternal line; photostimulable luminescence; potassium, sodium chloride, and sodium lactate [solu... |
| SS | disulfide; sacrosciatic; saline soak; saline solution; saliva sample; saliva substitute; Salmonella-... |
| SC | conditioned stimulus; sacrococcygeal; Sanitary Corps; scalenus [muscle]; scapula; Schwann cell; scia... |
| AC | Anticoagulant |
|---|---|
| LAC | Lupus AntiCoagulant |
| OAC | Oral anticoagulant |
| OAT | Oral anticoagulant therapy |
| r-TAP | Recombinant tick anticoagulant peptide |
| anticoagulant | <haematology, pharmacology> Any substance that prevents blood clotting. Those drugs administered for prophylaxis or treatment of thromboembolic disorders are heparin, which inactivates thrombin and several other clotting factors and which must be administered parenterally and the oral anticoagulants (warfarin, dicumarol and congeners) which inhibit the hepatic synthesis of vitamin K dependent clotting factors. Anticoagulant solutions used for the preservation of stored whole blood and blood fractions are acid citrate dextrose (ACD), citrate phosphate dextrose (CPD), citrate phosphate dextrose adenine (cPDA 1) and heparin. Anticoagulants used to prevent clotting of blood specimens for laboratory analysis are heparin and several substances that make calcium ions unavailable to the clotting process, including EDTA (ethylenediaminetetraacetic acid), citrate, oxalate and fluoride. (18 Nov 1997) |
|---|---|
| anticoagulant therapy | The use of anticoagulant drugs to reduce or prevent intravascular or intracardiac clotting. (05 Mar 2000) |
| vascular anticoagulant | <protein> Group of calcium-binding proteins that interact with acidic membrane phospholipids in membranes. They contain 4 or 8 repeats of a 61 amino acid domain that folds into 5 a helices. Also known by several other names (e.g. Lipocortins, endonexins), reflecting the history of their discovery in different contexts. See: lipocortin, endonexin I & II, calpactin, p70 and calelectrin. (18 Nov 1997) |
| lupus anticoagulant | An immunoglobulin that interferes with blood coagulation and has antithromboplastin activity. This immunoglobulin can prolong blood clotting and occurs in approximately 25% of people with lupus. (27 Sep 1997) |
| sodium acid citrate | Na3C6H5O7 -2H2O; trisodium citrate;used as diuretic, antilithic, systemic and urinary alkaliser, expectorant, and anticoagulant (in vitro). Synonym: sodium acid citrate. (05 Mar 2000) |
| sodium citrate | Na3C6H5O7 -2H2O; trisodium citrate;used as diuretic, antilithic, systemic and urinary alkaliser, expectorant, and anticoagulant (in vitro). Synonym: sodium acid citrate. (05 Mar 2000) |
| sodium citrate acid | C6H6O7Na-11/2H2O; disodium hydrogen citrate;same actions and uses as sodium citrate; in addition, it may be used in solutions of glucose without producing caramelization of the latter during autoclaving. (05 Mar 2000) |
| acid-citrate-dextrose | A citrate anticoagulant used for the collection and preservation of whole blood. It has largely been replaced by newer coagulants (CPD, Adsol) that allow for longer shelf life for blood and blood products. Acronym: ACD (05 Mar 2000) |
| ATP citrate lyase | ATP citrate (pro-3S)-lyase |
| ATP citrate (pro-3S)-lyase | <enzyme> An enzyme that, in the presence of ATP and CoA, catalyses the cleavage of citrate to yield acetyl CoA, oxaloacetate, ADP, and orthophosphate. This reaction represents an important step in fatty acid biosynthesis. Chemical name: ATP:citrate oxaloacetate-lyase ((pro-S)-CH2COO(-)--acetyl-CoA) (ATP-dephosphorylating) Registry number: EC 4.1.3.8 Synonym: citrate cleavage enzyme. (12 Dec 1998) |
| bismuth ammonium citrate | Ammoniocitrate of bismuth; an intestinal astringent. (05 Mar 2000) |
| bismuth citrate | Used in the making of bismuth and ammonium citrate. (05 Mar 2000) |
| caffeine citrate | Citrated caffeine, a mixture of equal parts of caffeine and citric acid. (05 Mar 2000) |
| calcium citrate | <chemical> A colourless crystalline or white powdery organic, tricarboxylic acid occurring in plants, especially citrus fruits, and used as a flavoring agent, as an antioxidant in foods, and as a sequestrating agent. Pharmacological action: antioxidants. (12 Dec 1998) |
| carbetapentane citrate | 2-(Diethylaminoethoxy)ethyl 1-phenylcyclopentyl-1-carboxylate citrate;it has atropine-like and local anaesthetic actions and effectively suppresses acute cough due to common upper respiratory infections. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|